vs

Side-by-side financial comparison of Dynatrace, Inc. (DT) and HUTCHMED (China) Ltd (HCM). Click either name above to swap in a different company.

Dynatrace, Inc. is the larger business by last-quarter revenue ($515.5M vs $270.8M, roughly 1.9× HUTCHMED (China) Ltd). Dynatrace, Inc. runs the higher net margin — 7.8% vs 0.7%, a 7.0% gap on every dollar of revenue. On growth, Dynatrace, Inc. posted the faster year-over-year revenue change (18.2% vs -16.5%). Dynatrace, Inc. produced more free cash flow last quarter ($27.2M vs $3.4M).

Dynatrace, Inc. is an American multinational technology company that provides an AI-powered observability platform. Their software is used to monitor, analyze, and optimize application performance, software development, cyber security practices, IT infrastructure, and user experience.

HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.

DT vs HCM — Head-to-Head

Bigger by revenue
DT
DT
1.9× larger
DT
$515.5M
$270.8M
HCM
Growing faster (revenue YoY)
DT
DT
+34.7% gap
DT
18.2%
-16.5%
HCM
Higher net margin
DT
DT
7.0% more per $
DT
7.8%
0.7%
HCM
More free cash flow
DT
DT
$23.9M more FCF
DT
$27.2M
$3.4M
HCM

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
DT
DT
HCM
HCM
Revenue
$515.5M
$270.8M
Net Profit
$40.1M
$2.0M
Gross Margin
81.4%
37.7%
Operating Margin
14.1%
-13.2%
Net Margin
7.8%
0.7%
Revenue YoY
18.2%
-16.5%
Net Profit YoY
-88.9%
-83.6%
EPS (diluted)
$0.13
$0.00

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DT
DT
HCM
HCM
Q4 25
$515.5M
$270.8M
Q3 25
$493.8M
Q2 25
$477.3M
$277.7M
Q1 25
$445.2M
$324.5M
Q4 24
$436.2M
Q3 24
$418.1M
Q2 24
$399.2M
$305.7M
Q1 24
$380.8M
Net Profit
DT
DT
HCM
HCM
Q4 25
$40.1M
$2.0M
Q3 25
$57.2M
Q2 25
$48.0M
$455.0M
Q1 25
$39.3M
$11.9M
Q4 24
$361.8M
Q3 24
$44.0M
Q2 24
$38.6M
$25.8M
Q1 24
$37.9M
Gross Margin
DT
DT
HCM
HCM
Q4 25
81.4%
37.7%
Q3 25
81.8%
Q2 25
82.1%
0.1%
Q1 25
80.9%
48.0%
Q4 24
81.1%
Q3 24
81.4%
Q2 24
81.3%
41.1%
Q1 24
81.1%
Operating Margin
DT
DT
HCM
HCM
Q4 25
14.1%
-13.2%
Q3 25
14.8%
Q2 25
13.1%
-1.3%
Q1 25
9.6%
-5.0%
Q4 24
10.9%
Q3 24
11.2%
Q2 24
10.5%
-9.0%
Q1 24
6.1%
Net Margin
DT
DT
HCM
HCM
Q4 25
7.8%
0.7%
Q3 25
11.6%
Q2 25
10.0%
163.8%
Q1 25
8.8%
3.7%
Q4 24
82.9%
Q3 24
10.5%
Q2 24
9.7%
8.4%
Q1 24
10.0%
EPS (diluted)
DT
DT
HCM
HCM
Q4 25
$0.13
$0.00
Q3 25
$0.19
Q2 25
$0.16
$0.52
Q1 25
$0.12
$0.01
Q4 24
$1.19
Q3 24
$0.15
Q2 24
$0.13
$0.03
Q1 24
$0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DT
DT
HCM
HCM
Cash + ST InvestmentsLiquidity on hand
$1.2B
$1.4B
Total DebtLower is stronger
$93.2M
Stockholders' EquityBook value
$2.7B
$1.2B
Total Assets
$4.1B
$1.8B
Debt / EquityLower = less leverage
0.08×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DT
DT
HCM
HCM
Q4 25
$1.2B
$1.4B
Q3 25
$1.3B
Q2 25
$1.3B
$1.4B
Q1 25
$1.1B
$836.1M
Q4 24
$1.0B
Q3 24
$1.0B
Q2 24
$1.0B
$802.5M
Q1 24
$836.9M
Total Debt
DT
DT
HCM
HCM
Q4 25
$93.2M
Q3 25
Q2 25
$93.4M
Q1 25
$82.8M
Q4 24
Q3 24
Q2 24
$82.1M
Q1 24
Stockholders' Equity
DT
DT
HCM
HCM
Q4 25
$2.7B
$1.2B
Q3 25
$2.8B
Q2 25
$2.7B
$1.2B
Q1 25
$2.6B
$759.9M
Q4 24
$2.6B
Q3 24
$2.1B
Q2 24
$2.1B
$740.1M
Q1 24
$2.0B
Total Assets
DT
DT
HCM
HCM
Q4 25
$4.1B
$1.8B
Q3 25
$4.1B
Q2 25
$4.1B
$1.8B
Q1 25
$4.1B
$1.3B
Q4 24
$3.7B
Q3 24
$3.3B
Q2 24
$3.3B
$1.3B
Q1 24
$3.4B
Debt / Equity
DT
DT
HCM
HCM
Q4 25
0.08×
Q3 25
Q2 25
0.08×
Q1 25
0.11×
Q4 24
Q3 24
Q2 24
0.11×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DT
DT
HCM
HCM
Operating Cash FlowLast quarter
$33.8M
$8.2M
Free Cash FlowOCF − Capex
$27.2M
$3.4M
FCF MarginFCF / Revenue
5.3%
1.2%
Capex IntensityCapex / Revenue
1.3%
1.8%
Cash ConversionOCF / Net Profit
0.84×
4.21×
TTM Free Cash FlowTrailing 4 quarters
$465.5M
$-96.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DT
DT
HCM
HCM
Q4 25
$33.8M
$8.2M
Q3 25
$32.0M
Q2 25
$269.7M
$-72.9M
Q1 25
$162.8M
$40.3M
Q4 24
$42.2M
Q3 24
$23.6M
Q2 24
$230.7M
$-39.8M
Q1 24
$131.7M
Free Cash Flow
DT
DT
HCM
HCM
Q4 25
$27.2M
$3.4M
Q3 25
$27.8M
Q2 25
$262.2M
$-82.2M
Q1 25
$148.2M
$32.5M
Q4 24
$37.6M
Q3 24
$20.1M
Q2 24
$227.4M
$-49.9M
Q1 24
$121.9M
FCF Margin
DT
DT
HCM
HCM
Q4 25
5.3%
1.2%
Q3 25
5.6%
Q2 25
54.9%
-29.6%
Q1 25
33.3%
10.0%
Q4 24
8.6%
Q3 24
4.8%
Q2 24
57.0%
-16.3%
Q1 24
32.0%
Capex Intensity
DT
DT
HCM
HCM
Q4 25
1.3%
1.8%
Q3 25
0.8%
Q2 25
1.6%
3.3%
Q1 25
3.3%
2.4%
Q4 24
1.1%
Q3 24
0.8%
Q2 24
0.8%
3.3%
Q1 24
2.6%
Cash Conversion
DT
DT
HCM
HCM
Q4 25
0.84×
4.21×
Q3 25
0.56×
Q2 25
5.62×
-0.16×
Q1 25
4.14×
3.38×
Q4 24
0.12×
Q3 24
0.54×
Q2 24
5.97×
-1.54×
Q1 24
3.47×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DT
DT

Subscription And Circulation$493.4M96%
Services$22.1M4%

HCM
HCM

Segment breakdown not available.

Related Comparisons